The Enterprise Value as of November 2025 (TTM) for PHAXIAM Therapeutics S.A. (PHXM) is 3.80M

According to PHAXIAM Therapeutics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.80M. This represents a change of -86.10% compared to the average of 27.34M of the last 4 quarters.

PHAXIAM Therapeutics S.A. (PHXM) Historical Enterprise Value (quarterly & annually)

How has PHXM Enterprise Value performed in the past?

The mean historical Enterprise Value of PHAXIAM Therapeutics S.A. over the last ten years is 39.19M. The current 3.80M Enterprise Value has changed 869.79% with respect to the historical average. Over the past ten years (40 quarters), PHXM's Enterprise Value was at its highest in in the December 2020 quarter at 116.71M. The Enterprise Value was at its lowest in in the December 2022 quarter at -13885719.35.

PHAXIAM Therapeutics S.A. (PHXM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PHAXIAM Therapeutics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PHAXIAM Therapeutics S.A. (PHXM) Average Enterprise Value

How has PHXM Enterprise Value performed in the past?

The current Enterprise Value of PHAXIAM Therapeutics S.A. (PHXM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PHAXIAM Therapeutics S.A. (PHXM) Enterprise Value vs. Peers

How is PHXM’s Enterprise Value compared to its peers?

PHAXIAM Therapeutics S.A.’s Enterprise Value is less than MEI Pharma, Inc. (10.34M), less than Nymox Pharmaceutical Corporation (4.84M), greater than MetaVia Inc. (-1392365.00), less than Traws Pharma, Inc. (4.83M), greater than COSCIENS Biopharma Inc. (-645869.00), greater than Pieris Pharmaceuticals, Inc. (-52477736.00), less than Dominari Holdings Inc. (64.62M), greater than Elevation Oncology, Inc. (-7613691.00), greater than AlphaTON Capital Corp. (2.23M), less than Kineta, Inc. (7.37M),

Build a custom stock screener for PHAXIAM Therapeutics S.A. (PHXM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PHAXIAM Therapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PHAXIAM Therapeutics S.A. (PHXM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PHAXIAM Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.